Skaff Michael C 4

4 · Vivos Therapeutics, Inc. · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

Vivos (VVOS) 10% Owner Michael C. Skaff Buys Shares

What Happened

Michael C. Skaff (reported as a 10% owner; Managing Director of SP Manager LLC, manager of V-Co Investors 3 LLC) made multiple purchases and derivative acquisitions in Vivos Therapeutics (VVOS) on March 31, 2026. The transactions total roughly 5,350,746 shares at $1.34 per share, with an aggregate reported value of about $7,169,999.
Transactions include a conversion of a $1.4M bridge promissory note into 1,044,777 shares (priced at $1.09 + $0.25 per share to meet Nasdaq minimum price rules) and other purchases/derivative acquisitions (noted as "Derivative" in the filing) that appear related to pre-funded warrants.

Key Details

Transaction date(s): March 31, 2026; Filing date: April 2, 2026 (Form 4 filed timely).
Price per share reported: $1.34.
Reported line items (shares and reported value):
- 1,044,777 shares — $1,400,001 (conversion of bridge note; F1)
- 308,848 shares — $413,856 (purchase)
- 429,957 shares — $576,142 (derivative)
- 1,783,582 shares — $2,390,000 (derivative)
- 1,783,582 shares — $2,390,000 (derivative)
Shares owned after the transaction: Not specified in the provided filing details.
Footnotes of note:
- F1: Conversion of a $1.4M bridge promissory note into common stock at $1.09 + $0.25 (Nasdaq minimum).
- F2: Skaff is MD of SP Manager LLC (manager of V-Co Investors 3 LLC) and disclaims beneficial ownership except for pecuniary interest.
- F3: Pre-Funded Warrant term ends on complete exercise (derivative items relate to warrants).
Transaction code: P = Purchase (including derivative-related acquisitions).

Context

These are purchases/conversions (a buy/ownership-increasing activity), which retail investors often view as a stronger signal than routine sales, though filings do not state intent or future plans.
The filing includes derivative-related entries (pre-funded warrants/convertible note conversion). Pre-funded warrants are effectively nearly-exercised claims on common shares and typically require a small remaining payment to convert into full shares.
As a reported 10% owner and manager of the investing LLC, Skaff’s report reflects institutional/affiliate activity; per F2, he disclaims beneficial ownership beyond his pecuniary interest.

Form 4

Period: 2026-03-31

10% Owner

Transactions

Purchase
Common Stock
[F1][F2]
2026-03-31$1.34/sh+1,044,777$1,400,001→ 1,044,777 total(indirect: By LLC)
Purchase
Common Stock
[F2]
2026-03-31$1.34/sh+308,848$413,856→ 1,353,625 total(indirect: By LLC)
Purchase
Pre-Funded Warrant
[F3][F2]
2026-03-31$1.34/sh+429,957$576,142→ 429,957 total(indirect: By LLC)
Exercise: $0.00From: 2026-03-31→ Common Stock (429,957 underlying)
Purchase
Series A Common Stock Warrant
[F2]
2026-03-31$1.34/sh+1,783,582$2,390,000→ 1,783,582 total(indirect: By LLC)
Exercise: $1.09From: 2026-03-31Exp: 2028-03-31→ Common Stock (1,783,582 underlying)
Purchase
Series B Common Stock Warrant
[F2]
2026-03-31$1.34/sh+1,783,582$2,390,000→ 1,783,582 total(indirect: By LLC)
Exercise: $1.09From: 2026-03-31Exp: 2031-03-31→ Common Stock (1,783,582 underlying)

Footnotes (3)

[F1]On March 31, 2026, V-Co Investors 3, LLC converted a bridge promissory note in the amount of $1,400,000 entered into between the reporting person and the Issuer into shares of the Issuer's common stock, based on $1.09 per share of Common Stock plus $0.25 per share in accordance with the Nasdaq minimum price rules.
[F2]Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
[F3]The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant.

1 file